课题基金 / 基金详情

The Production of More Effective Monoclonal Antibodies

The Production of More Effective Monoclonal Antibodies
生产更有效的单克隆抗体
批准号:
6648347
负责人:
MATTHEW D SCHARFF
金额:
$25.05万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-09-01 至 2005-08-31

项目摘要

项目成果

MATTHEW D SCHARFF的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): We propose to use our recent discovery that the forced expression of AID in hybridomas activates the somatic V region mutation to generate more effective monoclonal antibodies to agents used in bioterrorism. We will test high rates of V region mutation and isotype switching that can be activated in vivo with the conditional expression of AID. We will establish the optimum conditions for multiple rounds of mutation and selection to obtain the highest affinity antibodies with the full spectrum of isotypes. We will adapt techniques that we have used previously and we will develop new ones that will allow us to identify hybridoma subclones that are making human and mouse monoclonal antibodies that will more effectively neutralize the toxins and viruses and protect against microbial agents that are the primary agents used in bioterrorism and germ warfare. We will determine if such second-generation monoclonal antibodies to ricin and other toxins are truly more effective using mouse models.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hybridoma (Monoclonal Antibody) Core
  • 批准号:
    7706296
  • 项目类别:
  • 资助金额:
    $36.01万
  • 财政年份:
    2008
  • 负责人:
    MATTHEW D SCHARFF
  • 依托单位:
IMMUNO-ONCOLOGY
PROGRAM LEADERS
Mismatch repair in V region mutation and isotype switching
海外基金